1 To whom correspondence should be addressed Women can avoid the risks of surgery and anaesthesia. MifepriMisoprostol and mifepristone have been shown to be stone in combination with misoprostol is highly effective effective for medical abortion up to 9 weeks of gestation.
for first trimester medical abortion (Norman et al., 1991) . When used alone, the successful complete abortion rate Alternative regimens had been explored because mifepristone dropped to~60%. It has been demonstrated that by adding was not readily available in many countries. Methotrexate water to misoprostol, the success rate rose to 92%. This is followed by misoprostol has also been shown to be effective the first randomized study to investigate the efficacy of (Creinin et al., 1995) . However, side-effects related to methomisoprostol and water versus misoprostol alone for first trexate and the possibility of teratogenicity limit its popularity. trimester medical abortion in women at ≤ 9 weeks of Misoprostol is a synthetic prostaglandin E1 analogue that gestation. Eighty women were randomly assigned to group was initially used for the treatment of gastric ulcer. We have 1 (water added to misoprostol) and group 2 (misoprostol shown that it is a safe and effective cervical priming agent alone). Vaginal misoprostol 800 µg was given on days 1, 3 prior to vacuum aspirations in first trimester abortion (Ngai and 5. If the woman did not require vacuum aspiration et al., 1995, 1996) . It is also an effective abortifacient when during the period up to the return of first menstruation given in repeated doses in second trimester abortion (Ho et al., after medical abortion, the outcome was classified as 1997). The results of misoprostol alone in first trimester complete abortion. The incidence of side-effects and the medical abortion were disappointing. The complete abortion acceptability were assessed through a standardized quesrates were only 61-66% (Bugalho et al., 1996 ; Koopersmith tionnaire during and after the abortion. The complete and Mishel, 1996) . A 92% complete abortion rate in first abortion rate appeared higher when water was added but trimester medical abortion (amenorrhoea Ͻ70 days) has been the difference did not reach statistical significance. Gastroachieved simply by adding water to the misoprostol tablets intestinal side-effects were common but well tolerated in prior to vaginal insertion (Carbonell et al., 1997) . This was, both groups. Overall, 40% of the women preferred a however, the only published series that showed a satisfactory surgical method in the future because of the high failure result. We decided to perform this prospective study to find rate. With an overall complete abortion rate of 85%, it is out whether addition of water onto misoprostol tablets before probably not a clinically acceptable method even if the insertion can improve the efficacy of misoprostol alone on addition of water can improve the results. We conclude first trimester medical abortion. that the addition of water onto misoprostol tablets does not improve its efficacy in first trimester medical abortion. Misoprostol alone is not recommended for medical abortion Materials and methods (up to 9 weeks of pregnancy) because of the high failure vacuum aspiration has been shown to be associated with contraindication to the use of misoprostol (mitral stenosis, glaucoma, sickle cell anaemia, diastolic pressure Ͼ100 mm Hg, bronchial uterine perforation, cervical injuries and excessive haemor-asthma); (ii) history or evidence of thrombo-embolism, severe or (60) 22 (56) only (no water group). On day 1, women in group 1 received vaginal Married 15 (38) 17 (42) misoprostol 800 µg with 3 drops of water added onto each tablet; Divorced 1 (2) 1 (2) women in group 2 received vaginal misoprostol 800 µg without Nulliparous (%) 32 (80) 30 (75) water. They stayed in the day ward for a 4 h clinical observation
Menstrual delay (days) 21.6 Ϯ 7.9 22.0 Ϯ 6.6 period (hourly recordings of blood pressure and pulse rate). The time if it occurred, were recorded on the data forms. They were assessed
by one of the investigators at the end of the 4 h period. Women were
asked to bring back the tissue mass if it was passed at home. They
were advised to come back if excessive bleeding or abdominal pain was noted. On days 3 and 5, vaginal misoprostol (same treatment as
Values in parentheses are percentages. There were no significant differences between the groups.
that on day 1) was inserted and the observations were repeated. They were followed up again on days 15 and 43. Transvaginal ultrasound scan was performed in all women on day 15. Patients were examined
Results
and the bleeding patterns were checked on day 43. For those presenting
Patients' characteristics are presented in Table I . A total of 73 with persistent bleeding or when menstruation had not returned, a women out of 80 completed the medical treatment. In all, further follow-up appointment was made. The outcome of treatment was classified as: (i) complete abortion; seven women in group 2 dropped out of the study and
(ii) incomplete abortion; (iii) missed abortion; and (iv) live pregnancy.
underwent surgical treatment after two doses of misoprostol.
The initial judgement about the outcome of therapy was made at the No statistically significant differences were obtained when follow-up visit on day 15. If the ultrasound findings showed a live the demographic characteristics were compared between the pregnancy (i.e. fetal heart activity present) on day 15, vacuum two groups.
aspiration would be performed and the aspirates were sent for
The incidence of side-effects is shown in Table II . No histological examination. If the ultrasound findings on day 15 were statistically significant differences were obtained for the frecompatible with missed abortion (identifiable gestational sac without quency of any side-effects between the groups. All patients fetal heart activity), the investigator had the option of either terminaconsidered that the side-effects were tolerable, transient and tion of the pregnancy by vacuum aspiration or awaiting spontaneous decreased gradually after the first day of treatment. Nausea expulsion of the products of conception. The choice between these and vomiting were common but were well tolerated. About two alternatives was left to the principal investigator after discussion with the subject. If the ultrasound findings were compatible with one-fifth of patients in both groups complained of breast complete or incomplete abortion, no further action would be taken tenderness and half of them complained of fatigue which was unless there was heavy bleeding or signs of pelvic infection. In these probably related to the pregnancy itself. Uterine cramps were women the final judgement would be made on day 43. If no emergency the most common problem (75 and 57% in groups 1 and 2 or elective vacuum aspiration was necessary during the period up to respectively). The analgesia requirement was similar between the first menstruation, the outcome was classified as complete abortion.
the two groups (55.8 and 55.3% in groups 1 and 2 respectively).
Tissues removed by vacuum aspiration were sent for histological
The majority of these patients needed a single dose of oral confirmation.
doloxene. The incidence and intensity of pain did not vary in Those who did not require vacuum aspiration were defined as relation to the treatment group or gestational age. The duration successful cases. Failure was defined as the recourse to surgical of bleeding was well accepted in all women. The pre-and abortion either due to method failure or change of patients' decision.
post-treatment haemoglobin values were comparable between
The incidence of side-effects, duration of vaginal bleeding, dosage the two groups and there was no significant drop of haemoof analgesic requirement and infection rate between the two groups were also compared. A standardized questionnaire was given to globin after treatment. No patient suffered from excessive patients during and after the abortion in order to assess acceptability bleeding or required blood transfusion. The mean time for to the patients. The differences in the discontinuous variables were onset of bleeding was at 6.9 h in group 1 and 4.4 h in group 2.
analysed by χ 2 test or Fisher's exact test. The differences of continuous
The outcome of termination of pregnancy was shown in variables were analysed by Student's t-test for normally distributed Table III . The rates of success were similar in the two groups.
data and the Mann-Whitney test for skewed data.
In group 1, treatment was successful for 34 of the 40 patients with 68.4% (95% CI, 43-87%; not significant) in group 2.
Vaginal misoprostol for medical abortion Table I for definition of groups.
contributed to the decision making included the possible exogenous prostaglandin given by i.m. injection or intravaginal pessary is a highly effective means of inducing abortion in early pregnancy (Rodger and Baird, 1987; World Health Organization, 1989) . However, the search for a stable oral Worry about the effect of surgery on future pregnancy 11 (14) abortion occurred in 95% of the women (Norman et al., 1991) Confident about new medical technology 10 (13) with pregnancy Ͻ56 days. However, mifepristone is only available in four countries (France, UK, Sweden and China). This limits the widespread use of this regimen for first trimester The cases in which failure occurred were classified (Winikoff, 1996) as follows: (i) method failure: group 1 (n ϭ medical abortion. Intramuscular or oral methotrexate, followed by misoprostol, has also been shown to be effective in first 6) and group 2 (n ϭ 7) either live pregnancy or missed abortion on day 15 requiring vacuum aspiration, (ii) women's trimester medical abortion. The success rates range from 83 to 98% (Creinin et al., 1995 (Creinin et al., , 1996 Hausknecht, 1995) . own decision: group 2 (n ϭ 7), changed their decision and opted for vacuum aspiration before completion of medical However, the methotrexate-related side-effects and the potential teratogenicity in future pregnancy limit its popularity. treatment, (iii) doctor's decision. No women required transfusion or i.v. therapy and none of them had emergency surgery
The efficacy of vaginal misoprostol alone for first trimester medical abortion varies widely, from 47 to 94% (Creinin et al., because of excessive pain or bleeding.
Seven women withdrew from the study. They all belonged 1994; Carbonell et al., 1997) . The latter group (Carbonell et al., 1997) used three doses of 800 µg every 48 h in to group 2, the no water group. Three of them withdrew on day 3 and four of them withdrew on day 5. All of them had women with pregnancy length Ͻ70 days. He modified the administrative procedure by adding 3 drops of water with suction evacuation with no complication.
The reasons for choosing medical abortion are listed in misoprostol. The complete abortion rate in his study was 92%, which was comparable to that obtained from using mifepristone Table IV . It was noticed that worry about risks and complications of surgery was the major reason. Other factors that together with misoprostol (Normal et al., 1991) . However, the size of the study was small and no control group was included. abortion up to 9 weeks of pregnancy because of the high failure rate and low acceptability by patients. Further study We therefore conducted a randomized trial to evaluate the use of misoprostol (with and without water) in medical abortion focusing on the medical abortion up to 7 weeks may be worthwhile. up to 9 weeks of gestation.
We showed that there was an apparent but not significant trend towards achieving higher complete abortion rate when References water was added to misoprostol in medical abortion up to 9 Bugalho, A., Faundes, A., Jamisse, L. et al. (1996) Evaluation of the weeks of pregnancy. However, this did not reach statistical effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception, 53, 243-246. significance and the difference was less than that estimated Carbonell, J.L.L., Varela, L., Velazco, T. and Fernandez, T. (1997) The use from previous results (Carbonell et al., 1997) . With the overall of misoprostol for termination of early pregnancy. Contraception, 55, complete abortion rate of 85%, it is probably not a clinically 165-168. acceptable method even if the addition of water can improve Creinin, M.D. and Vittighoff, E. (1994) 
